当前位置: 首页 > 期刊 > 《世界中医药》 > 20187
编号:13593086
芍药苷和芍药内酯苷的抗抑郁作用与NO/cGMP信号转导通路的相关性(4)
http://www.100md.com 2018年4月1日 《世界中医药》 20187
     [9]李鸿娜,颜红.中医药对抑郁动物模型海马结构影响的研究进展[J].世界中医药,2015,10(11):18021805.

    [10]张潇,田俊生,刘欢,等.抗抑郁中药新药研发进展[J].中国中药杂志,2017,42(1):2933.

    [11]吴芳.赤芍总苷/淫羊藿总黄酮对实验性抑郁及脑5HT和β肾上腺素受体的影响[J].现代预防医学,2005,32(7):744746,764.

    [12]陈文伟.石菖蒲、赤芍醇提取物对实验性抑郁及血管活性肠肽和P物质的影响[J].华西医学,2006,21(2):321322.

    [13]Steru L,Chermat R,Thierry B,et al.The tail suspension test:a new method for screening antidepressants in mice[J].Psychopharmacology(Berl),1985,85(3):367370.

    [14]李苒,高杉,李琳,等.抑郁症发病机制的研究进展[J].天津中医药,2013,30(2):121125.

    [15]Saeedi Saravi SS,Arefidoust A,Saeedi Saravi SS,et al.Mammalian target of rapamycin(mTOR)/nitric oxide system possibly modulate antidepressantlike effect of 17αethinyl estradiol in ovariectomized mice[J].Biomed Pharmacother,2017,89:591604.

    [16]王景霞,刘妍,张建军.一氧化氮与抑郁症[J].现代医学,2011,39(1):104107.

    [17]Ostadhadi S,Imran Khan M,NorouziJavidan A,et al.Antidepressant effect of pramipexole in mice forced swimming test:A cross talk betweendopamine receptor and NMDA/nitric oxide/cGMP pathway[J].Biomed Pharmacother,2016,81:295304.

    (2017-08-15收稿責任编辑:芮莉莉), http://www.100md.com(吴丽 王丽丽 李伟 侯燕 王景霞 张建军)
上一页1 2 3 4